Physician profile
Curtis D Johnson
NPI 1427042852
$37,227.47
in general payments reported to CMS, 2019-2025
12 companies · $92.19 in 2025
The $92.19 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $16K · 2021: $2,017 · 2022: $8,331 · 2023: $7,448 · 2024: $2,941 · 2025: $92.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $481.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $36,451.98 | 2019-2024 | |
| Inspire Medical Systems, INC. | $200.39 | 2024 | Inspire |
| Stryker Corporation | $161.17 | 2019-2022 | |
| Alk-Abello, INC | $93.99 | 2019 | |
| Optinose US, INC. | $89.74 | 2019-2025 | |
| Genzyme Corporation | $57.74 | 2024-2025 | |
| Glaxosmithkline, LLC. | $54.18 | 2022-2025 | Nucala |
| Kaleo, INC. | $36.60 | 2022-2023 | Auvi-Q |
| Acclarent, INC | $29.26 | 2019 | |
| Smith+Nephew, INC. | $28.80 | 2020 | |
| Itamar Medical INC | $23.62 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.